Law firms Rising stars: Jaspreet Takhar – ‘EU regulators are preparing an avalanche of new laws that are going to have a monumental impact on pharma and medtech’ Sophie Chan · 9 February 2024 · 4 min read Profile Life Sciences Yearbook 2024 Baker McKenzie’s Jaspreet Takhar on the future of digital health solutionsWhat made you decide to specialise in life sciences law? Your limit of 1 article in 30 days is up. Please login for full access or subscribe. Corporate users - click here for simple access (no password needed). For more information, please contact [email protected] Related ContentMore in this categoryM&A perspectives: Melissa FogartyLaw firmsIman Tribak26 Jun 2024M&A perspectives: Jennifer BethlehemLaw firmsIman Tribak26 Jun 2024M&A perspectives: Lorenzo CorteLaw firmsIman Tribak26 Jun 2024Sponsored thought leadership: China life sciences – Transaction insights and notable industry trendsPractice areasGuest Blog9 Feb 2024The Legal 500 view: Healthy competitionLaw firmsBen Wheway9 Feb 2024Life Sciences Yearbook 2024 – Editor’s letterPractice areasGeorgina Stanley9 Feb 2024Transatlantic firms outstrip peers on five-year PEP growth, LB100 data revealsLaw firmsAlex Ryan20 Dec 2024A good time to be mid-tier: private equity interest on the rise as mid-market thrivesLaw firmsTom Cox18 Dec 2024The LB100 ranked by PEP: firms push partner profits to new heights as associate pay debate rumbles onLaw firmsAlex Ryan18 Dec 2024